Inhibrx Inc (INBX)
34.05
-0.04
(-0.12%)
USD |
NASDAQ |
Apr 26, 16:00
34.05
0.00 (0.00%)
After-Hours: 17:49
Inhibrx Total Assets (Quarterly): 307.89M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 307.89M |
| September 30, 2023 | 372.73M |
| June 30, 2023 | 213.17M |
| March 31, 2023 | 253.72M |
| December 31, 2022 | 290.88M |
| September 30, 2022 | 164.85M |
| June 30, 2022 | 193.21M |
| March 31, 2022 | 161.18M |
| December 31, 2021 | 150.45M |
| Date | Value |
|---|---|
| September 30, 2021 | 129.18M |
| June 30, 2021 | 141.89M |
| March 31, 2021 | 124.50M |
| December 31, 2020 | 143.74M |
| September 30, 2020 | 143.55M |
| June 30, 2020 | 21.30M |
| December 31, 2019 | 26.49M |
| June 30, 2019 | 48.73M |
| March 31, 2019 | 24.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.30M
Minimum
Jun 2020
372.73M
Maximum
Sep 2023
169.85M
Average
150.45M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 167.56B |
| Gilead Sciences Inc | 62.12B |
| Outlook Therapeutics Inc | 21.68M |
| Axonics Inc | 719.92M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 264.39M |
| Shareholders Equity (Quarterly) | 43.50M |
| Debt to Equity Ratio | 4.758 |
| Current Ratio | 5.245 |
| Net Debt Paydown Yield | -0.40% |